AstraZeneca (LSE:AZN) is navigating a period of robust growth and strategic challenges. Recent developments include an 18% ...

When “the Greater Good” Matters The business pages, and now the mainstream media, have been dominated over the last week with news of Pfizer’s proposed $106bn takeover of AstraZeneca, which would make ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AstraZeneca (LON:AZN) has had a rough month with its share price down 9.1%. But if you pay close attention, you ...

Astrazeneca chief executive Pascal Soriot (pictured) said the company was taking the arrests of eight or nine employees 'very ...

Sharma’s analysis would have taken into account AstraZeneca’s financial metrics, market dynamics, and potential for shareholder value creation, leading to his positive outlook on the company’s stock.

Sunil Verma, MD, of AstraZeneca envisions the future of cancer care, including the role of AI and streamlining screening ...

A healthy 27-year-old died from a reaction to the AstraZeneca vaccine after NHS mistakes meant he wrongly got the jab, a ...

LONDON, Sept 9 (Reuters) - Detailed results from one of AstraZeneca's (AZN.L), opens new tab key lung cancer trials released on Monday showed that its experimental precision drug did not ...

This is the online edition of ESMO in 30 Seconds, a pop-up newsletter from the European Society for Medical Oncology’s annual meeting in Barcelona, Spain. Sign up for the remaining editions here.

AstraZeneca has shared an early look at the performance of its in-house antibody-drug conjugate (ADC) technology, publishing phase 1 data on candidates that could compete with molecules from ...